From: Liz Hansen, reporting on
the glaucoma research project headed by Gary Johnson, DVM,
PhD at the University of Missouri-Columbia, College of
Veterinary Medicine.
Researchers are delighted to
report that a vastly improved mapping technology tool is now
available! The “SNP Chip” which radically increases the
speed at which samples can be processed and mapped, is due
from the manufacturer the second week in June. As only one
company is producing these chips and demand far exceeds
supply, the Missouri researchers have entered into
collaboration with Dr. Hannes Lohi in Finland. He will be
“running” samples sent from here as well as the European
samples submitted to him. It is anticipated that this run
will identify the location where the actual mutation should
be found with future procedures. Liz likened the process to
looking for an address with Mapquest: One starts with the
whole world — the total canine genetic makeup — and continue
to zoom in — to a country, a state, a city, and finally to
the precise street.
The goal remains to find a
genetic marker for the expression of glaucoma which would
identify whether Dandies are clear, carriers or affected.
She emphasized that it is crucial, particularly in a
small gene pool, that carriers and affected dogs remain in
the breeding population. Without sacrificing all the other
positive traits in our dogs, with identification and
selective breeding, the percentage of affected animals can
be steadily reduced overtime. As an example, she discussed
recent identification of the marker and a simple test for
another eye affliction in a numerically large breed. Running
projections following tests on a several thousand dog
sample, it was found that 20% of the breed appears clear,
40% carriers and 40% affected. Obviously, removing nearly
half of the population for one disease would be disastrous.
The scientists recommend that as above, these animals remain
in the breeding population: by continued selection to
maintain all other qualities of the breed and slowly moving
away from affected dogs in breeding, she projected an
essentially clear population could be achieved in about 20
years, roughly ten generations. In regard to Dandies, one
must surmise this would take somewhat longer, but still a
short period compared to the breed’s long history.
The project still is in great
need of samples, particularly of affected dogs plus their
normal relatives (siblings and parents). Collecting such
data has been a problem as the majority of cases of glaucoma
in the breed are late onset, with littermates scattered and
parents dead. Ms. Hansen suggests that samples from litters
sires and dams where glaucoma shows in the pedigree behind
them would be very appropriate, as a change in any dog’s
condition can be reported at a future date. For full
information on the project and how to submit samples, go to
the website:
www.caninegeneticdiseases.net Specific questions
about sample and pedigree submission may be sent to
hansenl@missouri.edu
or
devorej@missouri.edu.
Cathy Nelson
|